Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy

被引:22
|
作者
Li, Yafeng [1 ]
Yu, Yinxi [2 ]
VanderBeek, Brian L. [1 ,3 ,4 ]
机构
[1] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Prevent Ophthalmol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Clin Epidemiol & Biostat, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Leonard Davis Inst, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
BILLING CODES; MACULAR EDEMA; VISUAL-LOSS; HYPOXIA; HEMOGLOBIN; ACCURACY; CARE;
D O I
10.1038/s41433-019-0617-6
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/Aims To determine if anaemia and oxygen delivery-related co-morbidities (ODCs) affect progression from non-proliferative diabetic retinopathy (NPDR) to vision-threatening diabetic retinopathy (VTDR). Methods This is a retrospective cohort study using medical claims data from a large US insurer. Cohorts were created from all NPDR patients between 2002 and 2016. Primary exclusion criteria consisted of any previous diagnosis of proliferative diabetic retinopathy (PDR), diabetic macular oedema (DME) or treatment used in the care of VTDR. The main outcome was a new diagnosis of VTDR (DME or PDR), PDR, or DME. A time-dependent, multivariate Cox proportional hazard regression was used to determine the association between anaemia and other ODCs with NPDR progression. Results Of the total 69,982 NPDR patients included for analysis, 12,270, 2,162, and 10,322 progressed to VTDR, PDR and DME, respectively. Both mild and moderate/severe (mod/sev) anaemia were associated with an increased hazard for progression to VTDR (mild HR:1.10, 95% CI:1.04-1.16, p < 0.001; mod/sev HR:1.20, 95% CI:1.12-1.29, p < 0.001), PDR (mild HR:1.29, 95% CI:1.13-1.46, p < 0.001; mod/sev HR:1.43, 95% CI:1.21-1.69, p < 0.001), and DME (mild HR:1.06, 95% CI:1.00-1.13, p < 0.001; mod/sev HR:1.14, 95% CI:1.05-1.24, p < 0.001). ODCs such as chronic pulmonary disease and history of blood disorder/cancer were also significantly associated with an increased hazard for NPDR progression (HR > 1.00, p < 0.001 for all comparisons). Conclusions Anaemia, independent of kidney disease, appears to play a significant role in progression from NPDR to VTDR, PDR, or DME. Concurrently, association of ODCs with NPDR progression lends support to the underlying mechanisms of anaemia in the pathogenesis of diabetic retinopathy.
引用
收藏
页码:934 / 941
页数:8
相关论文
共 50 条
  • [1] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Yafeng Li
    Yinxi Yu
    Brian L. VanderBeek
    Eye, 2020, 34 : 934 - 941
  • [2] Glucagon-like peptide-1 receptor agonists are associated with decreased risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Tauqeer, Zujaja
    Bracha, Peter
    Hua, Peiying
    Cui, Qi N.
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [3] Non-proliferative diabetic retinopathy
    Danek, Dagmara
    Larsen, Brian
    Anderson-Nelson, Susan
    DM DISEASE-A-MONTH, 2021, 67 (05):
  • [4] Risk factors for progression to vision threatening diabetic retinopathy
    VanderBeek, Brian L.
    Li, Yafeng
    Bavinger, J. Clay
    Yu, Yinxi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 224 - 225
  • [5] Pupillary responses in non-proliferative diabetic retinopathy
    Jason C. Park
    Yi-Fan Chen
    Norman P. Blair
    Felix Y. Chau
    Jennifer I. Lim
    Yannek I. Leiderman
    Mahnaz Shahidi
    J. Jason McAnany
    Scientific Reports, 7
  • [6] RISK FACTORS THAT AFFECT NON-PROLIFERATIVE DIABETIC RETINOPATHY 2018
    Vaca Orellana, Susan Catherine
    Mederos Molina, Katiuska
    Escariz Borrego, Liliam Iris
    Diaz Rodriguez, Jorge Alberto
    REVISTA SAN GREGORIO, 2019, (29): : 59 - 65
  • [7] Automatic grading of non-proliferative diabetic retinopathy
    Suman S.
    Tiwari A.K.
    Singh K.
    Research on Biomedical Engineering, 2023, 39 (03) : 677 - 692
  • [8] Progression to Vision-Threatening Retinopathy Complications Following Panretinal Laser for Proliferative Diabetic Retinopathy
    Muste, Justin C.
    Valentim, Carolina C. S.
    Iyer, Amogh I.
    Mammo, Danny A.
    Alsaloum, Peter
    Xu, Colin M.
    Russell, Matthew W.
    Singh, Rishi P.
    Talcott, Katherine E.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2022, 53 (04): : 186 - +
  • [9] Statin use and the risk of progression to vision threatening diabetic retinopathy
    Meer, Elana
    Bavinger, J. Clay
    Yu, Yinxi
    Hua, Peiying
    McGeehan, Brendan
    VanderBeek, Brian L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (06) : 652 - 660
  • [10] Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy
    Citirik, Mehmet
    Berker, Nilufer
    Haksever, Hulya
    Elgin, Ufuk
    Ustun, Huseyin
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (02) : 321 - 325